BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/15/2024 2:49:03 AM | Browse: 280 | Download: 869
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 89126
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Translational Research
Article Title Development of a novel staging classification for Siewert II adenocarcinoma of the esophagogastric junction after neoadjuvant chemotherapy
Manuscript Source Unsolicited Manuscript
All Author List Jian Zhang, Hao Liu, Hang Yu and Wei-xiang Xu
ORCID
Author(s) ORCID Number
Jian Zhang http://orcid.org/0000-0001-7688-6168
Hao Liu http://orcid.org/0000-0001-5809-6824
Funding Agency and Grant Number
Funding Agency Grant Number
Zhejiang Provincial Science and Technology Program 2023C03172
Corresponding Author Jian Zhang, MD, Chief, Chief Doctor, Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 1367 West Wenyi Road, Yuhang District, Hangzhou 310003, Zhejiang Province, China. ljzju001@126.com
Key Words Stage classification; Prognosis; Esophagogastric junction cancer; Neoadjuvant chemotherapy; Siewert type
Core Tip So far, the ideal staging classification for Siewert II AEG treated with neoadjuvant chemotherapy is lacking. Thus, we established nomogram based on the Cox regression model which incorporating variables associated with overall survival (OS) and disease-specific survival (DSS). The novel nomogram model showed the best performance compared with 8th American Joint Committee of Cancer pathological staging schemes of esophagus cancer and gastric cancer. The time-receiver operating characteristic curve of the novel nomogram showed an excellent predictive value in terms of 5-year OS [0.665 (0.626-0.704)] and 5-year DSS [0.675 (0.636-0.713)]. Finally, a friendly online web application was developed for clinical use.
Publish Date 2024-06-15 02:49
Citation

Zhang J, Liu H, Yu H, Xu WX. Development of a novel staging classification for Siewert II adenocarcinoma of the esophagogastric junction after neoadjuvant chemotherapy. World J Gastrointest Oncol 2024; 16(6): 2541-2554

URL https://www.wjgnet.com/1948-5204/full/v16/i6/2541.htm
DOI https://dx.doi.org/10.4251/wjgo.v16.i6.2541
Full Article (PDF) WJGO-16-2541-with-cover.pdf